Literature DB >> 11980170

Recommended structure for reporting economic evaluation on pharmaceuticals in Belgium.

Lieven Annemans1, Ralph Crott, Diana Degraeve, Dominique Dubois, Michel Huybrechts, Frank Peys, Hugo Robays, Jean Smets, Marc Tomas, Kathleen Vanschoubroek.   

Abstract

Pharmaco-economic evaluations become more important for the reimbursement of pharmaceuticals, and will be obligatory for new pharmaceutical drugs for which an added therapeutic value is claimed and a price premium is proposed by the manufacturer. Therefore, it is important to guide purchasers and providers of pharmaceutical care in their efforts related to the evaluation process. Standard Report Format can support the quality, transparency and exhaustiveness of the data submitted. A multidisciplinary task force developed a Standard Report Format for pharmaco-economic evaluations in Belgium.

Mesh:

Year:  2002        PMID: 11980170     DOI: 10.1023/a:1014896830042

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  2 in total

Review 1.  Budget-impact analyses: a critical review of published studies.

Authors:  Ewa Orlewska; Laszlo Gulácsi
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 2.  Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.

Authors:  Mireille M Goetghebeur; Monika Wagner; Hanane Khoury; Randy J Levitt; Lonny J Erickson; Donna Rindress
Journal:  BMC Health Serv Res       Date:  2008-12-22       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.